Monocyte, Lymphocyte, and Monocyte–Lymphocyte Ratio Responses to Treatment Phases in Pulmonary Tuberculosis Patients

Authors

  • Nurul Hidayathul Mahpudinah Restu Puskesmas Jonggon Jaya, Loa Kulu, Kutai Kartanegara, Kalimantan Timur, Indonesia
  • Leka Lutpiatina Medical Laboratory Technology, Poltekkes Kemenkes Banjarmasin, Indonesia
  • Ahmad Muhlisin Medical Laboratory Technology, Poltekkes Kemenkes Banjarmasin, Indonesia
  • Ratih Dewi Dwiyanti Medical Laboratory Technology, Poltekkes Kemenkes Banjarmasin, Indonesia

DOI:

https://doi.org/10.35916/thmr.v8i1.151

Keywords:

Lymphocytes, monocyte-lymphocyte ratio, monocytes, pulmonary tuberculosis, tuberculosis treatment

Abstract

Pulmonary tuberculosis is a chronic infectious disease that affects the balance of innate and adaptive immune responses, reflected in changes in hematological parameters, particularly monocyte and lymphocyte counts, and the monocyte-lymphocyte ratio (MLR). This study aimed to analyze differences in lymphocyte and monocyte counts and MLR values ??in pulmonary tuberculosis patients based on treatment phase. This cross-sectional analytical survey study involved 60 pulmonary tuberculosis patients divided into 0-month treatment groups, the intensive phase, and the continuation phase in Loa Kulu District from January to April 2025. Peripheral blood smears were stained with Giemsa to determine the percentage of lymphocytes and monocytes, and then the MLR value was calculated. Statistical analysis using one-way ANOVA showed significant differences in lymphocyte and monocyte counts between treatment groups (p<0.05). The mean lymphocyte count increased with treatment duration, while the mean monocyte count decreased, resulting in a decrease in the MLR value from 0.64 in the pre-treatment group to 0.29 in the intensive phase and 0.22 in the continuation phase. The decrease in MLR reflects an improved immune response balance and decreased systemic inflammation during tuberculosis therapy. The results of this study indicate that MLR demonstrated variation across treatment phases, suggesting its potential relevance in the clinical assessment of TB patients.

References

Zumla A, George A, Sharma V, Herbert NH, Baroness Masham of Ilton, Oxley A, Oliver M. The WHO 2014 global tuberculosis report—further to go. Lancet Glob Health. 2015;3:e10–2.

Perhimpunan Dokter Paru Indonesia. Tuberkulosis: pedoman diagnosis dan penatalaksanaan di Indonesia. 2nd ed. Jakarta: PDPI; 2021. p. 2–12.

Naranbhai V, Fletcher HA, Tanner R, O'Shea MK, McShane H, Fairfax BP, Knight JC, Hill AV. Distinct transcriptional and anti-mycobacterial profiles of peripheral blood monocytes dependent on the ratio of monocytes:lymphocytes. EBioMedicine. 2015;2(11):1619–26. doi:10.1016/j.ebiom.2015.09.027.

Wang W, Wang LF, Liu YY, Yang F, Zhu L, Zhang XH. Value of the ratio of monocytes to lymphocytes for monitoring tuberculosis therapy. Can J Infect Dis Med Microbiol. 2019;2019:3270393.

Das B, Kashino SS, Pulu I, Kalita D, Swami V, Yeger H, Felsher DW, Campos-Neto A. CD271+ bone marrow mesenchymal stem cells may provide a niche for dormant Mycobacterium tuberculosis. Sci Transl Med. 2013;5(170):170ra13. doi:10.1126/scitranslmed.3004912.

Bashir A, Abufatima A, Mohamedani A. Impact of pulmonary tuberculosis on total and differential peripheral blood leukocyte count. Int J Trop Med. 2014;9:33–7.

Sampath P, Moideen K, Ranganathan UD, Bethunaickan R. Monocyte subsets: phenotypes and function in tuberculosis infection. Front Immunol. 2018;9:1726. doi:10.3389/fimmu.2018.01726.

Guilliams M, Ginhoux F, Jakubzick C, Naik SH, Onai N, Schraml BU, Segura E, Tussiwand R, Yona S. Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny. Nat Rev Immunol. 2014;14(8):571–8. doi:10.1038/nri3712.

Wang J, Yin Y, Wang X, Pei H, Kuai S, Gu L, Xing H, Zhang Y, Huang Q, Guan B. Ratio of monocytes to lymphocytes in peripheral blood in patients diagnosed with active tuberculosis. Braz J Infect Dis. 2015;19(2):125–31. doi:10.1016/j.bjid.2014.10.008.

Simanjuntak AM, Tovi I, Marbun UDP, Elisabet A. COVID-19 and pulmonary tuberculosis, between coinfection and reactivation from latent tuberculosis patient: a systematic review. J Indones Med Assoc. 2023;73(2):59–67. doi:10.47830/jinma-vol.73.2-2023-1006.

Aufani D, Azzahra L, Supriyanto S, Fatayati I, Nuswantoro A. Korelasi antara rasio neutrofil/limfosit dengan kadar C-reactive protein pada penderita tuberkulosis paru. Media Penelit Pengemb Kesehat. 2023;33(2):114–20. doi:10.34011/jmp2k.v33i2.2089.

Nabila R, Ayu PR, Wulan AJ. Hubungan antara kejadian tuberkulosis ekstra paru dengan kadar limfosit dan monosit di RSUD Dr H Abdul Moeloek Provinsi Lampung periode tahun 2018–2019. Medula. 2023;13(5):768–77.

Badan Kebijakan Pembangunan Kesehatan. SKI 2023 dalam angka. Jakarta: Kementerian Kesehatan Republik Indonesia; 2024. Accessed on 2026 Feb 7. https://www.badankebijakan.kemkes.go.id/ski-2023-dalam-angka/

de Waal AM, Hiemstra PS, Ottenhoff THM, Joosten SA, van der Does AM. Lung epithelial cells interact with immune cells and bacteria to shape the microenvironment in tuberculosis. Thorax. 2022;77(4):408–16.

Handoko B, Arliny Y, Priyanto H, Andayani N, Yanifitri DB. Clinically confirmed pulmonary tuberculosis new case patients before treatment and after intensive phase. J Respirol Indones. 2025;45(1):55–60.

Shima Y, Masuda T, Miwa N, Kida Y, Koketsu R, Kamiryo H, Sakurai T, Tada K. Monocytes predict prognosis and successful treatment in older patients with miliary tuberculosis. J Clin Tuberc Other Mycobact Dis. 2024;35:100437.

?tefanescu S, Coco? R, Turcu-Stiolica A, Mahler B, Meca AD, Giura AMC, Bogdan M, Shelby ES, Zamfirescu G, Pisoschi CG. Evaluation of prognostic significance of hematological profiles after the intensive phase treatment in pulmonary tuberculosis patients from Romania. PLoS One. 2021 Apr 1;16(4):e0249301. doi: 10.1371/journal.pone.0249301.

Suryana K, Dharmesti NWW, Rai IBN. High pretreatment level of neutrophil-to-lymphocyte ratio, monocyte-to-lymphocyte ratio and other factors associated with delayed sputum conversion in patients with pulmonary tuberculosis. Infect Drug Resist. 2022;15:5455–62.

Adane T, Melku M, Ayalew G, Bewket G, Aynalem M, Getawa S. Accuracy of monocyte-to-lymphocyte ratio for tuberculosis diagnosis and its role in monitoring anti-tuberculosis treatment: systematic review and meta-analysis. Medicine (Baltimore). 2022;101(44):e31539. doi:10.1097/MD.0000000000031539.

Naranbhai V, Kim S, Fletcher H, Cotton MF, Violari A, Mitchell C, Nachman S, McSherry G, McShane H, Hill AV, Madhi SA. The association between the ratio of monocytes:lymphocytes at age 3 months and risk of tuberculosis in the first two years of life. BMC Med. 2014;12:120. doi:10.1186/s12916-014-0120-7.

Downloads

Published

09-03-2026

How to Cite

Restu, N. H. M., Lutpiatina, L., Muhlisin, A., & Dwiyanti, R. D. (2026). Monocyte, Lymphocyte, and Monocyte–Lymphocyte Ratio Responses to Treatment Phases in Pulmonary Tuberculosis Patients. Tropical Health and Medical Research, 8(1), 46–54. https://doi.org/10.35916/thmr.v8i1.151

Most read articles by the same author(s)

1 2 3 > >>